The new FDA-approved ‘Wegovy HD’ offers three times the dose of semaglutide
The U.S. Food and Drug Administration announced Thursday that it is approving a new, high-dose Vigovi (semglutide) injection. The 7.2 mg dose, called Vigovi HD, is intended for weight loss and long-term weight loss maintenance in adult patients. This is three times the previous maximum dose of 2.4 mg. This marks the fourth approval in … Read more